Drug application
OXACILLIN SODIUM (OXACILLIN SODIUM)
Drugs@FDA ANDA 203950 · HOSPIRA
Key facts
| Drug name | OXACILLIN SODIUM |
|---|---|
| Active ingredients | OXACILLIN SODIUM |
| Application type | ANDA |
| Application number | 203950 |
| Company | HOSPIRA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 1GM BASE/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Dec 11, 2015 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: